Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details)

v3.10.0.1
Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details) - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Details    
Real estate note $ 114,282 $ 116,632
Working capital note 848,720 764,389
Accrued interest 3,054 0
Less current portion (40,604) (35,445)
Long term portion of notes receivable $ 925,452 $ 845,576